文献速递糖尿病肥胖与代谢综合征

整合人工智能饮食管理的数字健康照护平台用于糖尿病管理:随机对照试验48周结果

An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2023-01-01

这项48周、开放标签、随机、多中心临床试验纳入294例超重或肥胖的2型糖尿病成人,按1:1:1分为常规照护A组、自行使用数字整合健康照护平台B组、平台加医护人员反馈并间歇使用个人持续葡萄糖监测C组。主要终点A组与B组24周HbA1c变化差异;B组和C组24周及48周HbA1c下降均显著大于A组,B组和C组24周体重下降大于A组,C组48周体重下降大于A组。

要点

  • B组24周HbA1c下降0.32±0.58%,C组下降0.49±0.57%,均显著大于A组的0.06±0.61%。
  • 48周HbA1c变化B组-0.28±0.56%、C组-0.44±0.62%,均显著大于A组的0.07±0.78%。
  • 24周体重下降B组和C组均大于A组,48周体重下降仅C组大于A组。

核心结论

  • 在2型糖尿病成人中,使用整合人工智能饮食管理的数字健康照护平台可带来更好的血糖控制和更多体重下降。

研究设计与样本

  • 48周、开放标签、随机、多中心临床试验,纳入超重或肥胖的2型糖尿病成人,按1:1:1随机分为A组(常规糖尿病照护)、B组(自行使用数字整合健康照护平台)、C组(使用平台并接受医护人员反馈及间歇性个人持续葡萄糖监测)。
  • 共294例参与者被随机分配至A组(n=99)、B组(n=97)、C组(n=98)。
  • 主要终点为A组与B组从基线至24周HbA1c变化差异,次要终点包括从基线至48周HbA1c变化及随访期间体重变化。

主要发现

  • 从基线至24周HbA1c下降:B组-0.32±0.58%,C组-0.49±0.57%,A组-0.06±0.61%,B组和C组下降均显著大于A组。
  • 从基线至48周HbA1c变化:B组-0.28±0.56%,C组-0.44±0.62%,A组0.07±0.78%,B组和C组下降均显著大于A组。
  • 从基线至24周,B组和C组体重下降均大于A组;从基线至48周,C组体重下降大于A组。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated the efficacy of an integrated digital health care platform with artificial intelligence (AI)-based dietary management in adults with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: In this 48-week, open-label, randomized, multicenter clinical trial, overweight or obese adults with T2D were randomly assigned to one of three groups in a 1:1:1 ratio: group A received routine diabetes care; group B used the digital integrated health care platform by themselves; and group C used the platform with feedback from medical staff and intermittently applied personal continuous glucose monitoring. The primary end point was the difference of change in HbA1c from baseline to 24 weeks between groups A and B, while secondary end points included changes in HbA1c from baseline to 48 weeks and changes in body weight during follow-up. RESULTS: A total of 294 participants were randomly assigned to group A (n = 99), B (n = 97), or C (n = 98). The decreases in HbA1c from baseline to 24 and 48 weeks in group B (-0.32 ± 0.58% to 24 weeks and -0.28 ± 0.56% to 48 weeks) and group C (-0.49 ± 0.57% to 24 weeks and -0.44 ± 0.62% to 48 weeks) were significantly larger than those in group A (-0.06 ± 0.61% to 24 weeks and 0.07 ± 0.78% to 48 weeks). Groups B and C exhibited greater weight loss than group A from baseline to 24 weeks, and group C demonstrated more weight loss than group A from baseline to week 48. CONCLUSIONS: Among adults with T2D, use of an integrated digital health care platform with AI-driven dietary management resulted in better glycemia and more weight loss.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lee YB, Kim G, Jun JE, et al. An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes Care. 2023. PMID: 36821833. doi:10.2337/dc22-1929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。